- Specialise in human experimental models using human foetal brain tissue.- Perform bioinformatic analysis of human single-cell transcriptomics data.- Administrate cloud and high-performance computing facility for omics data and image analysis.- Employ two-photon time-lapse microscopy to study human neuron development.- Shortlisted for Wellcome Early-Career Award interviews.

- Executed computational analysis of single-cell multiome (transcriptome and chromatin accessibility).- Optimized single-nuclei preparation and library construction for next-generation sequencing.- Interrogated the epigenetic mechanisms underlying brain development in health and disease.

- Investigated the molecular mechanisms underlying brain development.- Employed high-throughput next-generation sequencing methods i.e. single-cell RNA sequencing.- Performed bioinformatic analysis of single-cell transcriptomics data using R and Python programming.- Tackled research questions using a range of molecular and pharmacological approaches.

- Involved in preclinical drug safety screening assay development (patent: PCT/EP2014/055695)- Worked in collaboration with the biopharmaceutical company IQVIA (formerly Quintiles).- Identified and validated both on- and off-targets of cytokine storm-inducing drugs, including NIB1412, Campath, Herceptin, Avastin and Arzerra.- Isolated and cultured patient-derived blood outgrowth endothelial cells (BOECs) and peripheral blood mononuclear cells (PBMCs).- Optimised the BOEC:PBMC co-culture system to enable robust screening of severe drug adverse effects such as cytokine storm.